Registration for a live webinar on 'Gamma-delta T cells for immunotherapy of cancer' is now open.See webinar details
Dr. Scot Roberts CSO, Altimmune, USA1 Talk
Dr. Scot Roberts has served as the Chief Scientific Officer (CSO) for Altimmune since December 2012. He has over two decades of experience managing scientific operations in the fields of cancer and infectious disease and has led drug development efforts for small molecules and biologics with a focus on viral... read morevectors and antiviral therapies. Previously, as CSO for ImQuest BioSciences, Inc., he led scientific operations and business development initiatives. Prior to Imquest, he held leadership positions at Wellstat Biologics Corporation including Director, Research and Development where he was responsible for development of biologic candidates in oncology including a clinical-stage asset. Dr. Roberts completed a post-doctoral fellowship at the National Cancer Institute, Laboratory of Molecular Virology and received his Ph.D. from the Johns Hopkins School of Medicine, Department of Pharmacology and Molecular Sciences. Dr. Roberts has authored numerous publications and is an inventor on a broad portfolio of patents.